Relationship between cardiovascular risk factors and biomarkers with necrotic core and atheroma size: A serial intravascular ultrasound radiofrequency data analysis

International Journal of Cardiovascular Imaging

Volumn 28, Issue 4, 2012, Pages 695-703

  García García, Héctor M ^a,b   Klauss, Volker ^c   Gonzalo, Nieves ^a   Garg, Scot ^a   Onuma, Yoshinobu ^a   Hamm, Christian W ^d   Wijns, William ^e   Shannon, Jennifer ^f   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CARDIALYSIS   (Netherlands)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d KERCKHOFF HEART CENTER   (Germany)

^e CARDIOVASCULAR CENTER   (Belgium)

^f GLAXOSMITHKLINE   (United States)

Author keywords

Atherosclerosis; IVUS backscattering radiofrequency data analysis; Necrotic core

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD40 LIGAND; CREATININE; DARAPLADIB; GELATINASE B; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MYELOPEROXIDASE; PLACEBO;

ACUTE CORONARY SYNDROME; ADULT; AGE DISTRIBUTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; ATHEROMA; ATHEROMA SIZE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CATHETER; COMPUTER PROGRAM; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DATA ANALYSIS; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; GLOMERULUS FILTRATION RATE; HEART MUSCLE NECROSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTRAVASCULAR ULTRASOUND; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NECROTIC CORE; PERCENTAGE ATHEROMA VOLUME; PERCENTAGE OF NECROTIC CORE; PERCUTANEOUS CORONARY INTERVENTION; RADIOFREQUENCY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STENOSIS; WAIST CIRCUMFERENCE;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ACUTE CORONARY SYNDROME; AGED; BENZALDEHYDES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CD40 LIGAND; CORONARY ARTERY DISEASE; CORONARY VESSELS; CREATININE; DOUBLE-BLIND METHOD; ENZYME INHIBITORS; EUROPE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECROSIS; OXIMES; PEROXIDASE; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84865472160     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-011-9882-6     Document Type: Article

References (19)

1. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM (2000) Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20(5): 1262-1275 (Pubitemid 30262927)
2. Davies MJ (1992) Anatomic features in victims of sudden coronary death. Coronary artery pathology. Circulation 85(1 Suppl):I19-I24
3. Cheruvu PK, Finn AV, Gardner C, Caplan J, Goldstein J, Stone GW, Virmani R, Muller JE (2007) Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. J Am Coll Cardiol 50(10):940-949 (Pubitemid 47313605)
4. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937-952. doi:10.1016/S0140-6736(04) 17018-9 (Pubitemid 39208455)
5. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS (2005) Obesity and the risk of myocardial infarction in 27, 000 participants from 52 countries: a case-control study. Lancet 366(9497):1640-1649. doi:10.1016/S0140-6736(05)67663-5 (Pubitemid 41552419)
6. Serruys PW, Garcia-Garcia HM, Buszman P, Erne P, Verheye S, Aschermann M, Duckers H, Bleie O, Dudek D, Botker HE, von Birgelen C, D'Amico D, Hutchinson T, Zambanini A, Mastik F, van Es GA, van der Steen AF, Vince DG, Ganz P, Hamm CW, Wijns W, Zalewski A (2008) Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 118(11):1172-1182. doi:10.1161/CIRCULATIONAHA.108.771899
7. Mohler ER 3rd, Ballantyne CM, Davidson MH, Hanefeld M, Ruilope LM, Johnson JL, Zalewski A (2008) The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 51(17):1632-1641. doi:10.1016/j.jacc.2007.11.079 (Pubitemid 351635837)
8. Lindner JR, Dayton PA, Coggins MP, Ley K, Song J, Ferrara K, Kaul S (2000) Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation 102(5):531-538 (Pubitemid 30639971)
9. Virmani R, Burke AP, Farb A, Kolodgie FD (2006) Pathology of the vulnerable plaque. J Am Coll Cardiol 47(8 Suppl):C13-C18. doi:10.1016/j.jacc. 2005.10.065
10. Kolodgie FD, Burke AP, Skorija KS, Ladich E, Kutys R, Makuria AT, Virmani R (2006) Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 26(11):2523-2529. doi:10.1161/01.ATV.0000244681.72738.bc (Pubitemid 44607475)
11. Wilensky RL, Shi Y, Mohler ER 3rd, Hamamdzic D, Burgert ME, Li J, Postle A, Fenning RS, Bollinger JG, Hoffman BE, Pelchovitz DJ, Yang J, Mirabile RC, Webb CL, Zhang L, Zhang P, Gelb MH, Walker MC, Zalewski A, Macphee CH (2008) Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med 14(10):1059-1066. doi:10.1038/nm.1870
12. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R (1997) Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 336(18):1276-1282 (Pubitemid 27187780)
13. Burke AP, Kolodgie FD, Zieske A, Fowler DR, Weber DK, Varghese PJ, Farb A, Virmani R (2004) Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol 24(7): 1266-1271 (Pubitemid 38880019)
14. Nicholls SJ, Wolski K, Sipahi I, Schoenhagen P, Crowe T, Kapadia SR, Hazen SL, Tuzcu EM, Nissen SE (2007) Rate of progression of coronary atherosclerotic plaque in women. J Am Coll Cardiol 49(14):1546-1551. doi:10.1016/j.jacc.2006.12.039 (Pubitemid 46517965)
15. Barrett-Connor EL (1985) Obesity, atherosclerosis, and coronary artery disease. Ann Intern Med 103(6 (Pt 2)): 1010-1019 (Pubitemid 16211923)
16. Onat A, Avci GS, Barlan MM, Uyarel H, Uzunlar B, Sansoy V (2004) Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes Relat Metab Disord 28(8):1018-1025. doi:10.1038/sj.ijo (Pubitemid 38998708)
17. Zeller M, Steg PG, Ravisy J, Lorgis L, Laurent Y, Sicard P, Janin-Manificat L, Beer JC, Makki H, Lagrost AC, Rochette L, Cottin Y (2008) Relation between body mass index, waist circumference, and death after acute myocardial infarction. Circulation 118(5):482-490. doi:10.1161/CIRCULATION AHA.107.753483
18. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351(13):1285-1295. doi:10.1056/NEJMoa041365 (Pubitemid 39258422)
19. Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D, Berman L, Shi H, Buebendorf E, Topol EJ (2004) Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 292(18):2217-2225